PharmaVOICE Blog Post

Social Media: A Rich Data Source or a Can of Worms?

Posted By: Dan Limbach
December 19, 2017

The rise of health-related social media (SM) has been phenomenal. It has been estimated that there are over 2.5 billion patient posts from 50 million healthcare users. Health-related SM is increasingly recognized as a potentially important source of evidence. Studies are already being undertaken that aim to directly monitor drug safety and provide evidence of the opinions and unmet needs of large numbers of real patients.

The research field is embryonic, and as in any new field the subject is often viewed with both skepticism and enthusiasm from the pharmaceutical industry. Additionally, there are also important and complex ethical dimensions that should not be overlooked.

View On Demand webinar now  http://bit.ly/socialmedia-rich-data

This On Demand webinar addresses:

  • The complexities of converting social media into actionable evidence
  • The types of information this data source can reveal
  • Some of the challenges and ethical considerations of using social media
  • Application of SM data through case studies, including breast cancer, cluster headaches, multiple sclerosis, and surgical infections.

Key Learning Objectives

  • Navigate the complexities of converting social media to actionable evidence
  • Understand the challenges, along with the benefits, of using social media as a data source
  • Have insightful knowledge into the types of information this data source can reveal
  • Identify opportunities to use social media in evidence generation and analysis

View On Demand webinar now http://bit.ly/socialmedia-rich-data

Provided by Evidera

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.

FEEDBACK